EKF Diagnostics Holdings plc
EKDHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.27 | 0.08 | -0.58 | -0.01 |
| FCF Yield | 3.96% | 3.91% | 5.67% | 0.28% |
| EV / EBITDA | 18.60 | 20.69 | 18.51 | 24.88 |
| Quality | ||||
| ROIC | 2.74% | 6.16% | 2.84% | 6.61% |
| Gross Margin | 50.20% | 49.37% | 47.84% | 48.25% |
| Cash Conversion Ratio | 2.53 | 1.39 | 3.81 | 1.40 |
| Growth | ||||
| Revenue 3-Year CAGR | -7.37% | -2.28% | 9.06% | 15.49% |
| Free Cash Flow Growth | -12.02% | -20.88% | 1,935.14% | 132.04% |
| Safety | ||||
| Net Debt / EBITDA | -2.56 | -2.32 | -1.73 | -0.44 |
| Interest Coverage | 0.00 | 56.93 | 26.14 | 64.53 |
| Efficiency | ||||
| Inventory Turnover | 1.61 | 1.71 | 1.61 | 1.52 |
| Cash Conversion Cycle | 39.86 | 65.99 | 46.71 | 74.37 |